急性结膜炎

Sambursky R, Trattler W, Tauber S, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol. 2013;131:17-22.

• 摘要

Leibowitz HM. The red eye. N Engl J Med. 2000;343:345-351.

• 摘要

Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2012;(9):CD001211.

• 全文
• 摘要

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137. [Erratum in: MMWR Recomm Rep. 2015;64:924.]

• 全文
• 摘要

1.  American Academy of Ophthalmology. Preferred practice pattern: conjunctivitis, 2nd ed. San Francisco, CA: American Academy of Ophthalmology; 2003.

2.  Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86:5-17.

• 全文
• 摘要

3.  Manners T. Managing eye conditions in general practice. BMJ. 1997;315:816-817.

• 摘要

4.  Royal College of General Practitioners, Royal College of Ophthalmologists. Ophthalmology for general practice trainees. London: Medical Protection Society; 2001.

5.  Rietveld RP, ter Riet G, Bindels PJ, et al. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice. BMC Fam Pract. 2007;8:54.

• 全文
• 摘要

6.  Ganley JP, Roberts J. Eye conditions and related need for medical care among persons 1-74 years of age, United States 1971-72. In: DHHS, ed. Vital health statistics. Washington, DC: DHHS; 1983.

7.  Shields T, Sloan PD. A comparison of eye problems in primary care and ophthalmology practices. Fam Med. 1991;23:544-546.

• 摘要

8.  Dart JK, Buckley RJ, Monnickendan M, et al. Perennial allergic conjunctivitis: definition, clinical characteristics and prevalence. A comparison with seasonal allergic conjunctivitis. Trans Ophthalmol Soc UK. 1986;105:513-520.

• 摘要

9.  Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005;115:118-122.

• 摘要

10.  Buckley RJ. Allergic eye disease: a clinical challenge. Clin Exp Allergy. 1998;28(suppl 6):39-43.

• 摘要

11.  Bielory L. Differential diagnoses of conjunctivitis for clinical allergist-immunologists. Ann Allergy Asthma Immunol. 2007;98:105-114.

• 摘要

12.  Choi SH, Bielory L. Late-phase reaction in ocular allergy. Curr Opin Allergy Clin Immunol. 2008;8:438-444.

• 摘要

13.  Bremond-Gignac C, Donadieu J, Leonardi A, et al. Prevalence of vernal conjunctivitis: a rare disease? Br J Ophthalmol. 2008;92:1097-1102.

• 摘要

14.  Stenson S, Newman R, Fedukowicz H. Laboratory studies in acute conjunctivitis. Arch Ophthalmology. 1982;100:1275-1277.

• 摘要

15.  Weiss A, Brinser J, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr Med. 1993;122:10-14.

• 摘要

16.  Gigliotti F, Williams WT, Hayden FG. Etiology of acute conjunctivitis in children. J Pediatr. 1981;98:531-536.

• 摘要

17.  Fitch CP, Rapoza PA, Owens S. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology. 1989;96:1215-1220.

• 摘要

18.  Sambursky RP, Fram N, Cohen EJ. The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital emergency room. Optometry. 2007;78:236-914.

• 摘要

19.  Aoki K, Tagawa Y. A twenty-one-year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Int Ophthalmol Clin. 2002;42:49-54.

• 摘要

20.  Adleberg JM, Wittwer C. Use of the polymerase chain reaction in the diagnosis of ocular disease. Curr Opin Ophthalmol. 1995;6:80-85.

• 摘要

21.  Woodland RM, Darougar S, Thaker U, et al. Causes of conjunctivitis and keratoconjunctivitis in Karachi, Pakistan. Trans R Soc Trop Med Hyg. 1992;86:317-320.

• 摘要

22.  Ishii K, Nakazono N, Fujinaga K, et al. Comparative studies on aetiology and epidemiology of viral conjunctivitis in three countries of East Asia: Japan, Taiwan and South Korea. Int J Epidemiol. 1987;16:98-103.

• 摘要

23.  Isenberg SJ, Apt L, Valenton M, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681-688.

• 摘要

24.  Sambursky R, Tauber S, Schirra F, et al. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology. 2006;113:1758-1764.

• 摘要

25.  Laibson PR. Ocular adenoviral infections. Int Ophthalmol Clin. 1984;24:49-64.

• 摘要

26.  Ullman S, Roussel TJ, Culbertson WW, et al. Neisseria gonorrhoeae keratoconjunctivitis. Ophthalmology. 1987;94:525-531.

• 摘要

27.  Kinchington PR, Turse SE, Kowalski RP, et al. Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Invest Ophthalmol Vis Sci. 1994;35:4126-4134.

• 摘要

28.  Gordon YJ, Gordon RY, Romanowski E, et al. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology. 1993;100:1835-1839.

• 摘要

29.  Azar MJ, Dhaliwal DK, Bower KS, et al. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol. 1996;121:711-712.

• 摘要

30.  Sambursky R, Trattler W, Tauber S, et al. Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis. JAMA Ophthalmol. 2013;131:17-22.

• 摘要

31.  O'Brien TP, Jeng BH, McDonald M, et al. Acute conjunctivitis: truth and misconceptions. Curr Med Res Opin. 2009;25:1953-1961.

• 摘要

32.  Leibowitz HW, Pratt MV, Flagstad IJ, et al. Human conjunctivitis. I. Diagnostic evaluation. Arch Ophthalmol. 1976;94:1747-1749.

• 摘要

33.  Cheung D, Bremner J, Chan JT. Epidemic kerato-conjunctivitis: do outbreaks have to be epidemic? Eye (Lond). 2003;17:356-363.

• 摘要

34.  Chien L, Llaues-Rodas R. Application of immunofluorescent staining technique to the study of pathogenesis and rapid diagnosis of viral infections. Am J Clin Pathol. 1972;57:829-834.

• 摘要

35.  Van Rij G, Klepper L, Perkamp E, et al. Immune electron microscopy and a cultural test in the diagnosis of adenovirus ocular infection. Br J Ophthalmol. 1982;66:317-319.

• 摘要

36.  Wadell G, Allard A, Hierholzer JC. Adenoviruses. In: Murray PR, Baron EJ, Pfaller MA, et al., eds. Manual of clinical microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999.

37.  Elnifro EM, Cooper RJ, Klapper PE, et al. Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test? Br J Ophthalmol. 1999;83:622-627.

• 摘要

38.  Elnifro EM, Cooper RJ, Klapper PE, et al. Multiplex polymerase chain reaction for diagnosis of viral and chlamydial keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2000;41:1818-1822.

• 摘要

39.  Leibowitz HM. The red eye. N Engl J Med. 2000;343:345-351.

• 摘要

40.  Wirbelauer C. Management of the red eye for the primary care physician. Am J Med. 2006;119:302-306.

• 摘要

41.  Bal SK, Hollingworth GR. Red eye. BMJ. 2005;331:438.

• 摘要

42.  Vafidis G. When is red eye not just conjunctivitis? Practitioner. 2002;246:469-471,474-475,478-481.

• 摘要

43.  Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998;57:735-746.

• 摘要

44.  Weber CM, Eichenbaum JW. Acute red eye: differentiating viral conjunctivitis from other, less common causes. Postgrad Med J. 1997;101:185-196.

• 摘要

45.  Castillo M, Scott NW, Mustafa MZ, et al. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015;(6):CD009566.

• 全文
• 摘要

46.  Bonini S, Gramiccioni C, Bonini M, et al. Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review. Curr Opin Allergy Clin Immunol. 2007;7:446-449.

• 摘要

47.  Bielory L, Katelaris CH, Lightman S, et al. Treating the ocular component of allergic Rhinoconjunctivitis and related eye disorders. MedGenMed. 2007;9:35.

• 全文
• 摘要

48.  Abelson MB, Gomes PJ. Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing. Expert Opin Drug Metab Toxicol. 2008;4:453-461.

• 摘要

49.  Canadian Agency for Drugs and Technologies in Health. Olopatadine for the treatment of allergic conjunctivitis: a review of the clinical efficacy, safety, and cost-effectiveness. March 2012. http://www.cadth.ca (last accessed 30 November 2016).

• 全文

50.  Schechter BA. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. Expert Opin Drug Metab Toxicol. 2008;4:507-511.

• 摘要

51.  Oner V, Türkcü FM, Taş M, et al. Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety. Jpn J Ophthalmol. 2012;56:312-318.

• 摘要

52.  Gong L, Sun X, Qu J, et al. Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients. Clin Ther. 2012;34:1259-1272.

• 摘要

53.  Mantelli F, Santos MS, Petitti T, et al. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol. 2007;91:1656-1661.

• 全文
• 摘要

54.  Swamy BN, Chilov M, McClellan K, et al. Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data. Ophthalmic Epidemiol. 2007;14:311-319.

• 摘要

55.  Denis F, Chaumeil C, Goldschmidt P, et al. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis. Eur J Ophthalmol. 2008;18:858-868.

• 摘要

56.  Abelson MB, Heller W, Shapiro AM, et al; AzaSite Clinical Study Group. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. Am J Ophthalmol. 2008;145:959-965.

• 摘要

57.  Protzko E, Bowman L, Abelson M, et al; AzaSite Clinical Study Group. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Invest Ophthalmol Vis Sci. 2007;48:3425-3429.

• 全文
• 摘要

58.  Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2012;(9):CD001211.

• 全文
• 摘要

59.  Rose P. Management strategies for acute infective conjunctivitis in primary care: a systematic review. Expert Opin Pharmacother. 2007;8:1903-1921.

• 摘要

60.  Mah F. Bacterial conjunctivitis in pediatrics and primary care. Pediatr Clin North Am. 2006;53(suppl 1):7-10.

• 摘要

61.  Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract. 2001;51:473-477.

• 摘要

62.  Alfonso E, Crider J. Ophthalmic infections and their anti-infective challenges. Surv Ophthalmol. 2005;50(suppl 1):S1-S6.

• 摘要

63.  Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. Br J Gen Pract. 2005;55:962-964.

• 全文
• 摘要

64.  Karpecki P, Depaolis M, Hunter JA, et al. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Clin Ther. 2009;31:514-526.

• 摘要

65.  McDonald MB, Protzko EE, Brunner LS, et al. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Ophthalmology. 2009;116:1615-1623;e1.

• 摘要

66.  Tepedino ME, Heller WH, Usner DW, et al. Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis. Curr Med Res Opin. 2009;25:1159-1169.

• 摘要

67.  Kaufman HE. Ganciclovir: a promising topical antiviral gel for herpetic keratitis. Expert Rev Ophthal. 2009;4:367-375.

68.  Colin J. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes. Clin Ophthalmol. 2007;1:441-453.

• 全文
• 摘要

69.  Mahvan TD, Buckley WA, Hornecker JR. Alcaftadine for the prevention of itching associated with allergic conjunctivitis. Ann Pharmacother. 2012;46:1025-1032.

• 摘要

70.  Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137. [Erratum in: MMWR Recomm Rep. 2015;64:924.]

• 全文
• 摘要

71.  Haimovici R, Roussel TJ. Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftriaxone. Am J Ophthalmol 1989;107:511-514.

• 摘要

72.  D'Cruz OJ, Uckun FM. Stampidine: a selective oculo-genital microbicide. J Antimicrob Chemother. 2005;56:10-19.

• 摘要

73.  Gordon YJ, Romanowski EG, McDermott AM. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res. 2005;30:505-515.

• 摘要

74.  Monnerat N, Bossart W, Thiel MA. Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study [in German]. Klin Monbl Augenheilkd. 2006;223:349-352.

• 摘要

75.  Pelletier JS, Stewart K, Trattler W, et al. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009;26:776-783.

• 摘要

76.  Epstein SP, Pashinsky YY, Gershon D, et al. Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model. BMC Ophthalmol. 2006;6:22.

• 全文
• 摘要

77.  Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in a tertiary care eye clinic. Cornea. 2006;25:199-202.

• 摘要

78.  Colon LE. Keratoconjunctivitis due to adenovirus type 8: report on a large outbreak. Ann Ophthalmol. 1991;23:63-65.

• 摘要

79.  Ankers HE, Klapper PE, Cleator GM, et al. The role of a rapid diagnostic test (adenovirus immune dot blot) in the control of an outbreak of adenovirus type-8 keratoconjunctivitis. Eye. 1993;7:15-17.

• 摘要

80.  Jackson WB, Davis PL, Groh V, et al. Adenovirus type 19 keratoconjunctivitis in Canada. Can J Ophthalmol. 1975;10:326-333.

• 摘要

81.  Richmond S, Burman R, Crosdale E, et al. A large outbreak of keratoconjunctivitis due to adenovirus type 8. J Hyg (Lond). 1984;93:285-291.

• 摘要

82.  Hyde KJ, Berger ST. Epidemic keratoconjunctivitis and lacrimal excretory system obstruction. Ophthalm. 1988;95:1447-1449.

• 摘要

83.  Hammer LH, Perry HD, Donnenfeld ED, et al. Symblepharon formation in epidemic keratoconjunctivitis. Cornea. 1990;9:338-340.

• 摘要